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SESSION I: THE MOTOR
1.  Effect of Levosimendan on Slow Force Response 
to Sudden Stretch in Isolated Rat Papillary Muscle. 
OLEG LOOKIN, R. LISIN, and YURI LEONIDOVICH 
PROTSENKO, Institute of Immunology and Physiology of 
Russian Academy of Science, Ekaterinburg 620219, Russia
We tested whether change of Ca sensitivity of TnC is 
involved to slow force response (SFR) in health cardiac 
muscle. For that, we used levosimendan (LS). Rat RV 
papillary muscles were suddenly stretched from 85 to 
95% of LMAX, and force and calcium transient were mea-
sured during SFR in control solution and at 0.1, 1, and 
10 μM LS. Muscles were washed in Krebs (25C, 0.33 
Hz) with 1.1 and 2.5 mM [Ca2+]o to evaluate the effect 
of calcium sensitization on SFR at different Ca-satura-
tion levels.
LS decreased twitch force on any stage of SFR, but 
more pronouncedly at pre-stretch length and in lesser 
degree immediately after stretch. Regardless of [Ca2+]o 
and stage of SFR, LS signifi  cantly and dose dependently 
decreased time-to-peak tension and accelerated twitch 
relaxation, with no effect to peak [Ca2+]i. Nevertheless, 
LS dose dependently increased T80 and decreased T20 of 
Ca transient relaxation.
Regardless of [Ca2+]o concentration, SFR was either 
biphasic (fast initial rise, slow fall until steady state) 
or triphasic (fast initial rise, slow fall, slow rise). Some 
preparations showed apparent LS dose-dependent in-
crease of total SFR, whereas others showed the opposite 
effect. We have fi  tted fast initial rise of SFR by the equa-
tion F(t) = A*(1eBt). At all LS, the A parameter (am-
plitude) was signifi  cantly increased to 130% relatively 
control, whereas the B parameter (time constant) was 
lower than in control (not signifi  cantly). The effect was 
not dependent on [Ca2+]o.
Therefore, fast force response to sudden stretch 
(during 30 s) in rat myocardium might be at least 
partially due to changed Ca sensitivity of TnC to Ca2+. 
Slow response (several minutes after stretch) is caused 
by slow dynamics of intracellular Ca2+ rather than fur-
ther change in Ca sensitivity. It is also possible that in 
the range of 0.1 to 10 μM, LS acts not only as a calcium 
sensitizer, but it also increases cAMP levels, which could 
explain accelerated relaxation.
2.  Dystrophin and Utrophin Have Distinct Effects on 
the Microsecond Dynamics of Actin. EWA PROCHNIE-
WICZ, DAVIN HENDERSON, AVA YUN LIN, JAMES 
ERVASTI, and DAVID D. THOMAS, Department of Bio-
chemistry, Molecular Biology and Biophysics, University of 
Minnesota, Minneapolis, MN 55455
Dystrophin and utrophin bind actin in vitro with 
similar affi  nities, but with different molecular contacts. 
These differences are proposed to alter the elasticity 
of actin-dystrophin and actin-utrophin linkages to the 
sarcolemma, affecting the cell’s response to muscle 
stretches. To test this hypothesis, we have determined 
the effects of dystrophin and utrophin on the microsec-
ond dynamics of erythrosin iodoacetamide–labeled ac-
tin using transient phosphorescence anisotropy (TPA). 
Binding of dystrophin or utrophin to actin resulted in 
signifi  cant changes in the TPA decay. At a low level of 
actin saturation (20%), both proteins induced similar 
changes in actin dynamics, but at higher levels of satura-
tion, utrophin was more effective than dystrophin and 
induced more pronounced changes in the fi  nal anisot-
ropy, correlation time, and initial anisotropy of actin. 
The simplest interpretation of these changes is that 
utrophin restricted the amplitude and increased the 
rates of motion of the probe to a substantially larger ex-
tent than dystrophin. Further analysis indicated that the 
actin–utrophin complex is much more torsionally fl  ex-
ible than the actin–dystrophin complex. In addition, 
individual regions along the full-length proteins have 
unique properties that contribute differently to the ef-
fects on actin dynamics. Preliminary data on fragments 
containing all the proposed actin binding domains 
(DN-R17/UN-R10) show less effect on regulating rota-
tional amplitude and nearly no effect on rotational rate. 
Future experiments will investigate other fragments of 
dystrophin and utrophin and their functionally rel-
evant mutants to determine which structural elements 
of these proteins are critical in determining the fl  ex-
ibility of actin fi  laments, and what level of actin fl  exibil-
ity is physiologically optimal. In addition, site-directed 
labeling of dystrophin and utrophin will permit spec-
troscopic analysis of these proteins’ structural dynamics 
when free and bound to actin. These results will greatly 
aid in both understanding the pathophysiology of DMD 
and optimizing therapeutic designs using micro-dystro-
phin/micro-utrophin or antisense oligonucleotides.
3.  Assessment of the Effect of Cardiac Myosin Binding 
Protein C on “pCa–Velocity” Relationship Obtained in 
an In Vitro Motility Assay. D.V. SHCHEPKIN, G.V. 
KOPYLOVA, B.Y. BERSHITSKY, and L.V. NIKITINA, Insti-
tute of Immunology and Physiology of the Russian Academy of 
Science, Yekaterinburg 620219, Russia
An in vitro motility assay with regulated thin fi  laments 
was applied to assess a modulatory role of cardiac my-
osin binding protein C (cMyBP-C) on myosin motion 
regulation. A series of experiments was performed to 
obtain dependences of thin fi  lament movement veloc-
ity on calcium concentration in solution (in the range 2a
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of pCa = 5 to pCa = 8). Rabbit cardiac myosin with and 
without rabbit cMyBP-C was used. Corresponding “pCa–
velocity” curves revealed sigmoid form.
Insertion of cMyBP-C to the motility assay affected 
distinctly thin fi   lament sliding velocities at maximal 
calcium levels. Particularly, adding 130 nM cMyBP-C re-
sulted in a 43% slowing of thin fi  lament speed at saturat-
ing calcium concentration (pCa = 5) as compared with 
regulated thin fi  laments without cMyBP-C (2.08 ± 0.12 
μm/s vs. 3.65 ± 0.04 μm/s, respectively). The presence 
of cMyBP-C did not change calcium sensitivity estimated 
as pCa50 (pCa value corresponding to half maximum 
velocity). Hill coeffi  cients of cooperativity (h) were de-
termined for pCa–velocity relationships. The value of h 
did not differ signifi  cantly due to the cMyBP-C addition 
and varied around 6.
Our data found in the experiments with cardiac myo-
sin are in good agreement with the results obtained with 
skeletal myosin by others (Saber, W., K.J. Begin, D.M. 
Warshaw, and P. VanBuren. 2008. J. Mol. Cell. Cardiol. 
44:1053–1061; Razumova, M.V., J.F. Shaffer, A.Y. Tu, G.V. 
Flint, M. Regnier, and S.P. Harris. 2006. J. Biol.Chem. 
281:35846–35854). Thus, the addition of cMyBP-C to 
the motility assay using both cardiac and skeletal myosin 
resulted in the slowing of thin fi  lament velocity at a satu-
rating calcium concentration. However, our experimen-
tal model seems to be more relevant to the acto–myosin 
interaction in intact cardiomyocytes.
This work was supported by Program 27 of Presidium 
RAS.
4.  Insights into Myosin Function Based on the Kinetic 
and Structural Data. H. LEE SWEENEY,  University of 
Pennsylvania School of Medicine, Philadelphia, PA 19104
The sliding of actin and myosin fi  laments was pro-
posed as the basis of force generation and shortening in 
striated muscle. Although this is now generally accepted, 
the detailed molecular mechanism of how myosin uses 
ATP to generate force during its cyclic interaction with 
actin is only now being unraveled. New insights have 
come from the unconventional myosins, especially myo-
sin V and, more recently, myosin VI. These myosins are 
kinetically tuned to allow movement on actin fi  laments 
as a single, dimeric molecule, which has led to new ki-
netic, mechanical, and structural data that have fi  lled 
in missing pieces of the actomyosin–chemo–mechanical 
transduction puzzle.
5.  The Actomyosin Motor: Structure, Function, and 
Modulation, One Molecule at a Time. DAVID M. WAR-
SHAW, University of Vermont College of Medicine, Burling-
ton, VT, 05405
Myosin is a double-headed molecular motor that cy-
clically interacts with actin to generate force and mo-
tion with the energy derived from its hydrolysis of ATP. 
Using a combination of single molecule biophysical 
techniques and structural mutagenesis, critical domains 
of the myosin motor have been identifi  ed that are essen-
tial for force and motion generation as well as effective 
communication between its two heads. With this knowl-
edge, the molecular consequences of point mutations 
in both myosin and actin that lead to genetic forms of 
human cardiomyopathies can be understood.
SESSION II: ORGANIZATION,  
REGULATION, AND DISEASES OF THE  
CONTRACTILE APPARATUS
6.  During Muscle Atrophy, Components of the Thick, 
But Not Thin, Filaments Are Degraded by MuRF1-de-
pendent Ubiquitylation. SHENHAV COHEN, JEFFREY 
J. BRAULT, STEVEN P. GYGI, DAVID J. GLASS, DAVID 
M. VALENZUELA, CARLOS GARTNER, ESTHER 
LATRES, and ALFRED L. GOLDBERG, Department of Cell 
Biology, Harvard Medical School, Boston, MA 02115
Loss of myofi  brillar proteins is a hallmark of atrophy-
ing muscle. Expression of MuRF1, a ubiquitin ligase, 
is markedly induced during atrophy, and MuRF1 dele-
tion attenuates muscle wasting. We generated mice ex-
pressing a Ring-deletion mutant MuRF1, which binds 
but cannot ubiquitylate substrates. Mass spectrometry 
of the bound proteins in denervated muscle identifi  ed 
many myofi  brillar components. Upon denervation or 
fasting, atrophying muscles show a loss of myosin bind-
ing protein C (MyBP-C) and myosin light chains 1 and 
2 (MyLC1 and MyLC2) from the myofi  bril before any 
measurable decrease in myosin heavy chain (MyHC). 
Their selective loss requires MuRF1. MyHC is protected 
from ubiquitylation in myofi  brils by associated proteins, 
but it eventually undergoes MuRF1-dependent degrada-
tion. In contrast, MuRF1 ubiquitylates MyBP-C, MyLC1, 
and MyLC2, even in myofi  brils. Because these proteins 
stabilize the thick fi  lament, their selective ubiquitylation 
may facilitate thick fi  lament disassembly. However, the 
thin fi  lament components decreased by a mechanism 
not requiring MuRF1.
7.  The Mechanical Properties of Titin Molecules Iso-
lated from the Failing Heart. HELEN K. GRAHAM, 
MICHAEL J. SHERRATT, and ANDREW W. TRAFFORD, 
School of Medicine, University of Manchester, Manchester M13 
9PT, England, UK
The passive stiffness of cardiac muscle is primarily de-
termined by the giant protein titin. Alterations in the 
ratio of the relatively stiff (N2B) to compliant (NB2BA) 
titin isoforms have been indentifi  ed in both coronary 
artery disease and non-ischemic dilated cardiomyopa-
thy in the presence of decreased titin-based passive stiff-
ness (Makarenko, I., C.A. Opitz, M.C. Leake, C. Neagoe, 
M. Kulke, J.K. Gwathmey, F. del Monte, R.J. Hajjar, and 
W.A. Linke. 2004. Circ. Res. 95:708–716; Neagoe, C., M.   3a
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Kulke, F. del Monte, J.K. Gwathmey, P.P. de Tombe, R.J. 
Hajjar, and W.A. Linke. 2002. Circulation. 106:1333–
1341). It has been proposed, therefore, that changes in 
the mechanical properties of titin play a major role in 
the etiology of heart disease. This study aimed to deter-
mine if the tensile strength of isolated titin molecules is 
altered in the failing heart.
Heart failure was induced in adult male ferrets by 
ascending aortic coarctation (Graham, H.K., and A.W. 
Trafford. 2007. Am. J. Physiol. 292:H1364–H1372). All 
procedures accorded with The UK Animals (Scientifi  c 
Procedures) Act, 1986. Titin molecules were isolated 
from the left ventricle (Soteriou, A., M. Gamage, and 
J. Trinick. 1993. J. Cell Sci. 104:119–123) and aligned 
and stretched by a molecular combing technique that 
uses a receding meniscus to apply a tensile force of 60 
pN (Tskhovrebova, L., and J. Trinick. 1997. J. Mol. Biol. 
265:100–106; Sherratt, M.J., C. Baldock, J.L. Haston, 
D.F. Holmes, C.J. Jones, C.A. Shuttleworth, T.J. Wess, 
and C.M. Kielty. 2003. J. Mol. Biol. 332:183–193).
After molecular combing, titin molecules were visu-
alized by atomic force microscopy. In contrast to non-
combed molecules, combed titin appeared straightened 
and beaded with discernable fi  laments between beads. 
The mean molecular diameter of titin (calculated as 
height above substrate) was decreased in failing hearts 
compared with control (0.26 ± 0.001 vs. 0.33 ± 0.001 
nm; P < 0.001; n = 104–130 molecules, 3 animals per 
group). This difference was more pronounced in the 
shorter molecules (<3.5 μm).
The mean distance between beads was increased in 
failing hearts (49.3 ± 1.5 vs. 126.8 ± 4.5 nm; P < 0.001; 
n = 370–429, 3 animals per group). No signifi  cant dif-
ference was observed in the mean contour lengths of 
titin from sham and heart failure tissue after molecular 
combing.
In conclusion, the decreased titin molecular diam-
eter combined with an increased inter-bead distance 
suggests that titin from failing hearts is less resistant to 
tensile forces when compared with control, and it may 
help to explain the decreased titin-based passive tension 
observed in diseased hearts.
8.  Myosin Binding Protein C Function in Cardiac Mus-
cle. SAMANTHA P. HARRIS, JUSTIN F. SCHAFFER, 
and KRISTINA L. BEZOLD, University of California, 
Davis, Davis, CA 95618
Myosin binding protein C (MyBP-C) is a thick fi  lament 
protein of vertebrate sarcomeres that limits cross-bridge 
cycling kinetics and reduces myocyte power output. 
Mutations in the gene encoding cardiac MyBP-C are a 
leading cause of inherited cardiomyopathies, but the 
mechanisms by which MyBP-C affects cardiac function 
and by which mutations in cMyBP-C cause disease are 
not well understood. Here, we investigated the ability of 
the fi  rst four N-terminal domains (C0-C1-motif-C2) of 
cardiac (c) MyBP-C to affect actomyosin interactions and 
to interact with actin. Recombinant proteins containing 
the C1 and motif domains increased Ca2+ sensitivity of 
tension and increased rates of tension redevelopment 
(ktr) at submaximal [Ca2+] in permeabilized rat trabecu-
lae. Proteins containing these domains also biphasically 
activated and then inhibited the Ca2+-activated ATPase 
rates of heavy meromyosin and myosin S1 in solution. 
Cosedimentation binding assays demonstrated binding 
of the four N-terminal domains to F-actin at a 1:1 mo-
lar ratio (Kd 10 μM). Phosphorylation of the motif 
reduced binding to a 1:2 molar ratio but did not com-
pletely eliminate the effects of recombinant proteins to 
increase Ca2+ sensitivity of tension and ktr at submaximal 
[Ca2+] in permeabilized trabeculae. We propose that 
the functional effects of cMyBP-C are mediated in part 
through phosphorylation-sensitive interactions with the 
thin fi  lament.
Supported by NIH HL080367.
9. Developing the Hypothesis That Dysferlin Is 
Required for Stabilizing Muscle T-Tubule Connec-
tions to the Sarcolemma. JOHN HEUSER, LUCY 
LOULTCHEVA, TANYA TENKOVA, and ROBYN 
ROTH, Department of Cell Biology, Washington University 
School of Medicine, St. Louis, MO 63110, and Institute for 
Integrated Cell-Material Sciences (iCeMS), Kyoto University, 
Kyoto 606-8501, Japan
We will advance the hypothesis in this poster that 
muscle T-tubules are uniquely vulnerable to damage 
during eccentric contractions, and that the muscle pro-
tein dysferlin plays a special role in stabilizing T-tubule 
connections with the plasma membrane, or reestablish-
ing connections with the plasma membrane if and when 
T-tubules are damaged by this sort of contraction. Fur-
ther, we will illustrate that the reason for this T-tubule 
vulnerability, which is unique to muscle, is due to the 
fact that the surface membrane of the muscle fi  ber, the 
sarcolemma, is pinned down to the special extracellu-
lar matrix that surrounds all muscle fi  bers and stabilizes 
them, so the surface membrane cannot slip laterally. 
We will then illustrate how the T-tubule system, which 
connects everywhere to the sarcolemma to spread ex-
citation throughout the muscle fi  ber, is itself pinned 
down to certain positions in the myofi  lament lattice of 
the internal sarcoplasmic contractile apparatus. These 
competing physical constraints, we will argue, mean 
that whenever the internal myofi  lament lattice becomes 
displaced laterally from its natural starting point distri-
bution relative to the surrounding sarcolemma (as it 
likely does during eccentric contraction), the T-tubule 
origins and insertions must become stretched and, con-
sequently, T-tubules become vulnerable to rupture or 
evulsion from the cell surface. We will further illustrate 
how and why this sort of T-tubule evulsion would inter-
rupt excitation-contraction coupling in the affected 4a
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region of the muscle fi  ber and likely cause a local fl  accid 
paralysis, which could promote further plasmalemmal/
sarcomere dislocation and further T-tubule rupture, 
thus propagating the muscle damage. Finally, we will 
conclude that if dysferlin is not the protein that helps to 
prevent such T-tubule damage or helps to heal it, discov-
ering whatever protein does do this job will become just 
as important for understanding all the muscular dystro-
phies as is understanding the role of dysferlin itself.
10. Confi   guration of Myosin-binding Protein C in 
Skeletal Muscle. HUGH E. HUXLEY,1 MASSIMO 
RECONDITI,2 and THOMAS IRVING,3 1Rosenstiel Center, 
Brandeis University, Waltham, MA 02453;  2Physiology De-
partment, University of Florence, 50019 Sesto Fiorentino, Italy; 
3IIT Chicago and BioCAT, APS Argonne National Labora-
tory, Argonne, IL 60439
Frog striated muscle gives a pair of x-ray meridional 
refl  ections at the spacings of 419 and 442 Å, which 
Offer (CSH Symp. 1972. 37:83–97) and Rome (ibid., 
331–339) have shown are related to the disposition of C 
protein in two sets of bands at 430-Å intervals on either 
side of the H-zone, giving rise to interference fringes 
that sample the underlying 430-Å refl  ection. However, 
there are problems with this simple interpretation.
We have studied these refl  ections at high resolution 
on the BioCAT beam line at the Argonne National 
Laboratory, in both relaxed and contracting muscles, 
and during the onset of activation. In resting muscle, 
two main peaks can generally be seen in the relevant re-
gion, and usually at 419 and 442 Å as previously de-
scribed, but the latter peak is approximately four times 
more intense than the former, which would require an 
underlying sampled peak at 437 Å. It seems very un-
likely that the C protein repeat is different from that of 
the myosin fi  lament to which it is attached (429.6 Å), 
although Squire et al. (Squire, J.M., P.K. Luther, and C. 
Knupp. 2003. J. Mol. Biol. 331:713–724) have suggested 
that C protein may interact in relaxed muscle with spe-
cifi  c sites on actin to produce such an effect. We think 
another explanation is more probable, namely a dou-
ble-interference effect.
The second component would be a “forbidden” fi  rst-
order myosin refl   ection, as discussed by Malinchik 
and Lednev (Malinchik, S.B., and V.V. Lednev. 1992. J. 
Muscle Res. Cell Motil. 13:406–419), arising because of 
systematic axial displacements of myosin cross-bridges 
(average repeat of 143.2 Å) within the 429.6-Å helical 
repeat. The interference fringes generated by this sys-
tem would interact in a complex way with those from C 
protein because the refl  ections would in general have 
different phases. We fi  nd that the observed pattern, 
with the very strong 442-Å refl  ection, can be modeled 
very satisfactorily, even when both underlying peaks are 
kept at 429.6 Å.
Some other relevant observations are also described.
11. A Contraction-dependent Pathway Regulates 
Myofi  bril Organization during Skeletal Muscle Devel-
opment In Vivo. MANUELA LAHNE, CHRISTINA 
KRIVCEVSKA, and RACHEL ASHWORTH, Queen Mary 
University of London, School of Biological and Chemical Sci-
ences, London E1 3NS, England, UK
The earliest movements (17–22 hpf) in zebrafi  sh em-
bryos are characterized by spontaneous muscle contrac-
tions driven via acetylcholine-generated Ca2+ signals. 
Mutant lines lacking key components of the excitation–
contraction (E-C) pathway, the acetylcholine receptor, 
and the dihydropyridine receptor (DHPR) show dis-
rupted skeletal muscle development, specifi  cally shorter 
sarcomeres and longer, misaligned myofi  brils (Brennan, 
C., M. Mangoli, C.E.F. Dyer, and R. Ashworth. 2005. J. 
Cell Sci. 118:5181–5190). Based on evidence from these 
mutants, we propose that myofi  bril organization is con-
trolled downstream of membrane depolarization. The 
underlying intracellular signaling mechanisms are cur-
rently still unknown. Ca2+-mediated muscle contraction 
or Ca2+ signals acting independently of contraction 
could be involved in myofi  bril organization downstream 
of membrane depolarization. To distinguish between 
these two mechanisms, we used a pharmacological ap-
proach using the myosin II inhibitor blebbistatin to 
block muscle contraction. Movement was blocked for a 
period of 7 hours starting at 17 hpf, and skeletal muscle 
morphology was subsequently examined using immuno-
cytochemistry. Slow muscle fi  bers of blebbistatin-treated 
embryos (10, 50 μM) displayed misaligned myofi  brils 
similar to the mutants lacking E-C coupling, suggest-
ing that muscle contraction is a critical regulatory step. 
However, as blebbistatin inhibits both muscle and non-
muscle myosin II, it might affect not only muscle fi  ber 
but also neuronal development. Axon outgrowth was 
similar in control and blebbistatin-treated embryos, but 
an apparent increase in neurite number and the loss of 
varicosities were observed. Disruption to the neuronal 
pathfi  nding might affect E-C coupling upstream of con-
traction and be the underlying cause of the myofi  ber 
phenotype. Assessment of functional neuromuscular 
communication by measurement of Ca2+ signals in mus-
cle fi  bers revealed that E-C coupling remained intact. 
Collectively, our data suggest that a functional contrac-
tile apparatus is required for myofi  bril organization. 
The late steps of muscle differentiation that rely upon 
embryonic movement may be regulated by a novel con-
tractile-dependent mechanism.
12.  Integration of Signaling at the Level of Sarcomeres 
with Electrical and Metabolic Signaling in the Heart. R. 
JOHN SOLARO, Department of Physiology and Biophysics, 
University of Illinois at Chicago, College of Medicine, Chicago, 
IL 60612
Emerging evidence indicates that beyond their role 
as molecular motors, sarcomeric proteins are important   5a
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in effi  cient coordination of electrical, mechanical, and 
chemical signals and the matching of energy demand 
to energy supply. Sarcomeric proteins sense mechani-
cal, chemical, and redox state and serve as sites of signal 
reception from G protein–coupled receptors and intra-
cellular G protein–controlled processes. In turn, sarco-
meric proteins—especially at the Z-disk—participate in 
signal transduction by acting as docking and shuttle sites 
for kinases, phosphatases, and transcription factors. Sig-
naling and signal transduction at the level of sarcom-
eres control cardiac dynamics, growth, and remodeling. 
Mechano-electrical feedback is also now understood to 
involve Ca2+ ions buffered by sarcomeric proteins. Re-
cent evidence also demonstrates linkages among ele-
ments in control of metabolic activity and sarcomeric 
function. For example, kinases such as PKD and AMP 
kinase not only regulate metabolic pathways, but also 
affect sarcomeric response to Ca2+. The challenge is to 
fully integrate these signaling processes at the level of 
sarcomeric proteins with signaling at the level of chan-
nels, transporters, and exchangers, as well as elements 
controlling redox state and metabolism. Disturbances 
in the role of sarcomeric proteins in integration of 
these processes represent a signifi  cant threat to homeo-
stasis. There are no better examples of this threat than 
familial cardiomyopathies genetically linked to muta-
tions in sarcomeric proteins. It is highly likely that these 
disturbances are also signifi  cant in acquired cardiac dis-
orders. There are promising data indicating that sarco-
meric proteins are useful as therapeutic targets in the 
treatment of cardiac disorders. These fi  ndings demand 
more complete understanding of the processes in sarco-
meric signaling from the molecular, cellular, organ, and 
whole body levels.
SESSION III: CALCIUM SIGNALING
13.  Altered Skeletal Muscle L-type Ca2+ Channel Activ-
ity in RyR1 R163C Malignant Hyperthermia-susceptible 
Mice. R.A. BANNISTER,1 E. ESTÈVE,2 K. LIU2, J.M. 
ELTIT,2 P.D. ALLEN,2 I.N. PESSAH,3 J. LÓPEZ,2 and 
K.G. BEAM,1 1Department of Physiology and Biophysics, Uni-
versity of Colorado-Denver, Aurora, CO 80045; 2Department 
of Anesthesiology, Perioperative and Pain Medicine, Brigham 
and Women’s Hospital, Boston, MA 02115; 3Department of 
Molecular Biosciences, School of Veterinary Medicine, Univer-
sity of California, Davis, Davis, CA 95616
In skeletal muscle, intermolecular communication 
between the L-type Ca2+ channel (1,4-dihydropyridine 
receptor [DHPR]) and the type 1 ryanodine recep-
tor (RyR1) is bidirectional; orthograde coupling is 
observed as depolarization-induced Ca2+ release from 
the sarcoplasmic reticulum, and retrograde coupling 
is manifested by increased L-type Ca2+ current. The 
pharmacogenetic disorder malignant hyperthermia 
(MH), which is triggered by exposure to heat, volatile 
anaesthetics, or depolarizing muscle relaxants, has 
been linked to >120 mutations in RyR1. In this study, 
we investigated whether DHPR activity is affected by 
one of these MH-linked mutations in RyR1 (R163C). 
To this effect, the I-V relationship for L-type currents 
in myotubes originating from R163C mice was shifted 
to more hyperpolarizing potentials (5 and 7 mV for 
HET and HOM, respectively) compared with wild-type 
myotubes (P < 0.001; ANOVA). Compared with wild-type 
myotubes, R163C HET and HOM myotubes both dis-
played a greater sensitivity to the 1,4-dihydropyiridine 
agonist ±Bay K 8644 (10 μM). Intramembrane charge 
movements of both HET and HOM myotubes were pro-
foundly shifted (>10 mV) to more hyperpolarized po-
tentials (P < 0.005; ANOVA). L-type currents in wild-type 
and HET myotubes displayed only modest (<35%) inac-
tivation after 30-s prepulses to 50, 30, and 10 mV, 
with no apparent difference between the two genotypes. 
Our results demonstrate that the RyR1 R163C mutation 
alters the voltage dependence of L-type channel activity 
and suggest that this hypersensitivity to membrane po-
tential contributes to increased myoplasmic Ca2+ levels 
associated with MH episodes.
Supported by NIH NS24444 and AR44750 to K.G. 
Beam, NIH AR052354 to P.D. Allen, and MDA 4155 to 
R.A. Bannister.
14. Cardiac  Ca2+ Cycling in Health and Arrhythmias. 
DAVID EISNER, TAKESHI KASHIMURA, LUIGI 
VENETUCCI, and ANDREW TRAFFORD, Unit of Car-
diac Physiology, The University of Manchester, Core Technology 
Facility, Manchester M13 9NT, England, UK
Most of the calcium that activates contraction in the 
ventricle comes from the sarcoplasmic reticulum (SR) 
and is released by the process of calcium-induced cal-
cium release (CICR). I will initially consider the mech-
anisms involved in regulating SR Ca content. We fi  nd a 
simple feedback mechanism in which an increase of SR 
Ca results in a larger systolic Ca transient that, in turn, 
increases Ca effl  ux from the cell, thereby decreasing 
SR Ca content. One consequence of this feedback is 
that maneuvers that increase the open probability of 
the RyR do not produce a maintained increase of sys-
tolic Ca.
If SR Ca content is increased above a threshold value, 
propagating waves of CICR are observed. These waves 
produce arrhythmogenic delayed afterdepolarizations 
(DADs) by activating the electrogenic NCX. This may 
also occur when SR Ca content is not elevated. One ex-
ample is in the presence of mutations of the RyR that 
can cause catecholaminergic polymorphic ventricular 
tachycardia (CPVT). Here, ventricular arrhythmias oc-
cur when catecholamine levels are increased during 
exercise and other stresses. This arises because the mu-
tated RyRs leak Ca during diastole.6a
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We have examined whether increasing the RyR leak 
per se produces diastolic Ca waves. When low concentra-
tions of caffeine are applied to increase RyR opening, Ca 
waves are only seen for a few seconds. The disappearance 
of the Ca waves is due to the accompanying decrease of 
SR Ca content. If, however, a -adrenergic agonist is fi  rst 
applied, caffeine produces waves in the steady state and 
we attribute this to the increase of SR Ca content due to 
the  agonist. This explains why the patients with mu-
tated RyRs develop arrhythmias during exercise.
The fi  nal part of the talk will consider how Ca wave 
–dependent arrhythmias might be treated. We fi  nd that 
decreasing the open probability of the RyR with tetracaine 
abolishes the Ca wave and increases the systolic Ca release.
15.  Changes in Ca2+ Transients and Phasic Contractions 
Induced by Uropathogenic E. coli (UPEC) in Smooth 
Muscle of the Rat Ureter. RACHEL V. FLOYD,1 ALI 
BAKRAN,2 CRAIG WINSTANLEY,3 SUSAN WRAY,1 and 
TED BURDYGA,1 1Department of Physiology, 2Vascular and 
Transplant Surgery Unit, Royal Liverpool University Hospital, 
and 3Division of Medical Microbiology and GU Medicine, Uni-
versity of Liverpool, Liverpool L69 3BX, England, UK
Urinary tract infection (UTI) remains a signifi  cant 
cause of postoperative complications after renal trans-
plant surgery and is the second most common infec-
tion seen in general practice. UTI, therefore, remains 
a constant and important clinical as well as economic 
problem. Ascending UTIs cause abnormal ureteric func-
tion, but little is known about the mechanisms causing 
this effect. Our preliminary studies have shown that 
prolonged intraluminal exposure of rat ureter to UPEC 
caused changes in ureteric smooth muscle contractility; 
however, the underlying mechanisms causing this effect 
were unclear. In the present study, changes in phasic con-
tractions and Ca2+ transients evoked by electrical fi  eld 
stimulation of Indo-1–loaded rat ureters during expo-
sure to UPEC were investigated. Exposure of ureters to 
pathogenic UPEC J96 on the luminal but not adventitial 
side of the ureter caused a time-dependent decrease in 
amplitude and duration of the Ca2+ transient and phasic 
contractions. Nonpathogenic TG2 under identical con-
ditions had little or no effect. Inhibition of K+ channels 
by TEA (5 mM) signifi  cantly but not completely reversed 
the inhibitory effects of J96 on Ca2+ transients and force. 
J96 also decreased Ca2+ transients and force induced by 
sustained high-K+ depolarization. Our data indicate that 
a decrease in the amplitude of the phasic contractions in-
duced by prolonged exposure to J96 in rat ureter smooth 
muscle is associated with a decrease in the amplitude and 
duration of the Ca2+ transient. The data suggest that this 
modulation of the Ca2+ transient and force in rat ureter 
smooth muscle induced by intraluminal J96 exposure is 
likely associated with an up-regulation of the activity of 
potassium channels and down-regulation of the activity 
of L-type calcium channels.
16. Structure–Function Relationships in Calcium 
Release Units. CLARA FRANZINI-ARMSTRONG, De-
partment of Cell and Developmental Biology, University of 
Pennsylvania, Philadelphia, PA 19104
The junctional domain of sarcoplasmic reticulum 
(jSR) is specialized for receiving signals from the plas-
malemma/transverse tubules and for releasing Ca2+ 
during muscle activation. The junctional face of the 
jSR, facing the T tubules, is occupied by a molecular 
complex composed of the transmembrane Ca2+ release 
channels (ryanodine receptors [RyRs]), the luminal 
protein calsequestrin (CSQ), the two membrane pro-
teins, junctin and triadin (Jct, Tr), which mediate CSQ-
RyR interactions, and several other components. Under 
the conditions prevailing within the SR lumen (physi-
ological ionic strength, mostly due to K+ Ca2+ ions), CSQ 
forms long linear polymers, and the fi  xed protein gel 
is clearly visible in the electron microscope. The lumi-
nal domains of Jct and Tr are detectable, but overall the 
two molecules are not clearly delineated. Overexpres-
sion and/or null mutation for the three proteins of the 
junctional complex (CSQ, Jct, and Tr) in skeletal and 
cardiac muscles reveal the contribution of these three 
components to the general architecture and mainte-
nance of the jSR.
17.  P2X Receptor–mediated Current in Myocytes from 
Renal Resistance Arteries. MAKSYM HARHUN,1 OLEK-
SANDR POVSTYAN,1,2 and DMITRI GORDIENKO,1,2 
1Ion Channel and Cell Signaling Centre, Division of Basic 
Medical Sciences, St George’s, University of London, London 
SW17 ORE, England, UK; 2Laboratory of Molecular Pharma-
cology and Biophysics of Cell Signaling, Bogomoletz Institute of 
Physiology, Kyiv 01024, Ukraine
Activation of ionotropic P2X purinoreceptors 
(P2XRs) elevates [Ca2+]i in renal vascular smooth mus-
cle cells (RVSMCs) triggering their contraction, thus, 
leading to renal vasoconstriction (Inscho, E.W. 2001. 
Am. J. Physiol. Renal Physiol. 280:F927–F944). By combin-
ing perforated patch tight-seal recording with confocal 
Ca2+ imaging (with fl  uo-4), we related the dynamics of 
[Ca2+]i mobilization to the kinetics of P2XR-mediated 
cationic current (IP2X) or changes in the membrane po-
tential of RVSMCs freshly isolated from interlobar and 
arcuate arteries of rat kidney and stimulated with 10 μM 
,-methyleneadenosine triphosphate (AMP-CPP). Un-
der current clamp, spike-like depolarization was associ-
ated with transient [Ca2+]i mobilization. Under voltage 
clamp, the [Ca2+]i transient was associated with IP2X acti-
vation: the current density was 141.5 ± 10.5 pA/pF (n = 
38) at Vh = 60 mV. Both spike-like depolarization and 
IP2X peaked before [Ca2+]i reached its maximum, sug-
gesting that IP2X is a major determinant of the spike-like 
depolarization, and that there are other than IP2X con-
tributors to the [Ca2+]i transient. RT-PCR analysis con-
ducted on 500 isolated RVSMCs showed the presence   7a
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of genes encoding P2X1R and P2X4R. Concentration 
dependence of IP2X activation with AMP-CPP revealed 
EC50 = 1.1 ± 0.1 μM (n = 6–7). IP2X induced by 10 μM 
AMP-CPP completely recovered from desensitization 
within 7 min. An increase in extracellular Ca2+ from 1 
to 5 mM reduced IP2X by 48 ± 6% (n = 5). Nanomolar 
concentrations of NF279 (selective inhibitor of P2X1R) 
reduced IP2X by 68 ± 3% in a concentration-dependent 
manner (EC50 = 8 ± 3 nM; n = 5–6). The residual cur-
rent was virtually insensitive to intermediate concen-
trations (0.2–20 μM) of NF279, but was inhibited with 
2 mM NF279. This study provides strong evidence that in 
rat RVSMCs, IP2X is mediated by at least two P2XRs sub-
types: P2X1R and P2X4R.
This work was supported by BHF (PG/08/062/25382 
and FS/06/077).
18.  Increase of Ryanodine Receptor Type-2 (RyR2) 
mRNA via an Activation of Cav1.3 Liter-type Ca2+ Chan-
nels. SUNOH KIM and HYEWHON RHIM, Life Sciences 
Division, Korea Institute of Science and Technology (KIST), 
Seoul 136-791, Korea
Ryanodine receptors (RyRs) are extremely impor-
tant for triggering muscle contraction and physically 
linked with L-type Ca2+ channels, providing an ampli-
fi  cation of the Ca2+ signal necessary to trigger muscle 
contraction. However, this coupling between L-type 
Ca2+ channels and RyRs has not been well character-
ized in the CNS. In this study, we used a yeast two-
hybrid screening system with the N terminus of rat 
Cav1.3 1 subunit (Cav1.3-NT) as bait and isolated a 
partial N-terminal amino acid sequence of RyR type 2 
(RyR2-NT) as a binding partner. We also demonstrated 
a physical association of Cav1.3 with RyR2 using GST 
pull-down, coimmunoprecipitation, and immunocy-
tochemistry assays. Depolarizing cells showed that the 
activation of L-type Ca2+ channels induced RyR open-
ing and led to RyR-dependent Ca2+ release, even in the 
absence of extracellular Ca2+. Furthermore, we found 
that RyR2 mRNA itself is increased by long-term treat-
ment of high-K via activation of L-type Ca2+ channels. 
These acute and long-term effects of high-K on RyRs 
were selectively blocked by small interfering RNA-
mediated silencing of Cav1.3. These results suggest a 
physical and functional interaction between Cav1.3 
and RyR2 and important implications of Cav1.3/RyR2 
clusters in translating synaptic activity into alterations 
in gene expression.
This work was supported by KIST Core-Competence 
Program, Brain Research Center of the 21st Century 
Frontier Research Program, and the KOSEF grant.
19.  Combined Mathematical Model of Electrical and 
Mechanical Activity of Ventricular Cardiomyocytes in 
Rat. P. KONOVALOV, O. SOLOVYOVA, L. KATSNEL-
SON, and V.S. MARKHASIN, Institute of Immunology and 
Physiology, Ural Division of the Russian Academy of Sciences, 
Yekaterinburg 620219, Russia
Previously, we have developed a mathematical model 
of the rat ventricular cardiomyocyte mechanical activity 
(Katsnelson, L.B., L.V. Nikitina, D. Chemla, O. Solovy-
ova, C. Coirault, Y. Lecarpentier, and V.S. Markhasin. 
2004. J. Theor. Biol. 230:385–405) that simulated a wide 
range of experimental phenomena, including load de-
pendence of relaxation, muscle inactivation due to the 
length change, and mechanical effects on Ca2+ transient 
in cardiomyocytes. The model was further parametri-
cally fi  tted to the guinea pig mechanics and combined 
with the Noble’98 model of guinea pig electrophysi-
ology. It proved to simulate major effects of cardiac 
mechano-electric feedback (Solovyova, O., N. Vikulova, 
L.B. Katsnelson, V.S. Markhasin, P.J. Noble, A. Garny, P. 
Kohl, and D. Noble. 2003. Inter. J. Bifurcation and Chaos. 
13:3757–3782; T. Sulman, L.B. Katsnelson, O. Solovy-
ova, and V.S. Markhasin. 2008. Bull. Math. Biol. 70:910–
949). Moreover, the model was successfully used in both 
theoretical and experimental models of cardiac hetero-
geneity (ibidem), particularly within our hybrid muscle 
duplex approach (Y.L. Protsenko, S.M. Routkevitch, 
V.Y. Gur’ev, L.B. Katsnelson, O. Solovyova, O.N. Lookin, 
A.A. Balakin, P. Kohl, and V.S. Markhasin. 2005. Am. J. 
Physiol. Heart Circ. Physiol. 289:H2733–H2746), where 
mechanical interaction between real and virtual mus-
cles was implemented in real time. These reasons make 
us combine our rat mechanical model and a model of 
rat electrophysiology (S.V. PandZit, R.B. Clark, W.R. 
Giles, and S.S. Demir. 2001. Biophys. J. 81:3029–3051), as 
rat is a commonly used experimental species. However, 
this new electro-mechanical model initially was not ad-
equate. Particularly, the model revealed Ca2+ overload 
of the cell when pacing at 1, 0.5, and 0.3 Hz. Moreover, 
the ratio between amounts of Ca2+ released from the SR 
and entering the cell via L-type channels was not realis-
tic and did not allow us to simulate contractions prop-
erly. Both inadequacies happened due to the equations 
for Ca2+ exchange between the SR and cytosol adopted 
from the Pandit’s model. Therefore, we completely re-
placed Pandit’s description of Ca2+ handling with that 
from our model and fi   tted several parameters. The 
combined model is now able to simulate correctly both 
electrical and mechanical cardiac performance in rat.
This work is supported by RFBR grants 08–04-01137 
and 07–04-96113, and a UBRAS multidisciplinary grant.
20.  The Mechanism of Myogenic Control of Arterial 
Diameter via Ca2+ Sensitization. MICHAEL P. WALSH, 
ROSALYN P. JOHNSON, AHMED F. El-YAZBI, KOSUKE 
TAKEYA, EMMA J. WALSH, and WILLIAM C. COLE, 
The Smooth Muscle Research Group, Faculty of Medicine, Uni-
versity of Calgary, Calgary, Alberta, Canada T2N 1N4
Contraction of resistance arteries in response to in-
creased transmural pressure (the myogenic response) 8a
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is a crucial determinant of peripheral vascular resis-
tance, blood pressure, and regional blood fl  ow control 
in several vascular beds, including the cerebral vascu-
lature. Understanding of the molecular mechanisms 
involved in the myogenic response, however, is incom-
plete. Myogenic constriction is dependent in part on 
pressure-induced membrane potential depolarization, 
but mechanisms in addition to changes in membrane 
potential and cytosolic free Ca2+ concentration ([Ca2+]i) 
have been implicated. For example, Ca2+ sensitization, 
i.e., an increase in force without a change in [Ca2+]i, 
has been suggested to contribute to the myogenic re-
sponse, but the underlying mechanism remains to be 
elucidated. We investigated the potential involvement 
of Rho-associated kinase (ROK)- and protein kinase C 
(PKC)-dependent phosphorylation of the myosin light 
chain phosphatase-targeting subunit (MYPT1) and of 
the 17-kD PKC-potentiated protein phosphatase 1 in-
hibitor protein (CPI-17), respectively, in the myogenic 
response of rat middle cerebral arteries. Inhibitors of 
ROK (Y27632 and H1152) and PKC (GF109203X and 
Gö6976) suppressed the myogenic response. Elevated 
pressure (60 and 100 mmHg vs. 10 mmHg) increased 
phosphorylation of MYPT1 at T855, but not T697, and 
enhanced myosin regulatory light chain (LC20) phos-
phorylation in an H1152-sensitive manner. However, 
pressure did not evoke CPI-17 phosphorylation, and in-
hibition of PKC did not affect the pressure-induced in-
creases in MYPT1 (T855) or LC20 phosphorylation. Our 
fi  ndings provide the fi  rst direct biochemical evidence 
that Ca2+ sensitization induced by ROK-dependent 
phosphorylation of MYPT1 at T855 (but not T697), with 
subsequent augmentation of LC20 phosphorylation and 
force generation, contributes to the myogenic response 
in the cerebral vasculature. On the other hand, suppres-
sion of the myogenic response by PKC inhibition can-
not be attributed to block of Ca2+ sensitization mediated 
by CPI-17 or MYPT1 phosphorylation.
Supported by grant MOP-10568 from the Canadian 
Institutes of Health Research.
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21.  Stretch-induced Muscle Damage and Duchenne 
Muscular Dystrophy. D.G. ALLEN,1 O.L. GERVASIO,1 
E.W. YEUNG,2 and N.P. WHITEHEAD1, 1School of Medi-
cal Sciences and Bosch Institute, University of Sydney, Sydney, 
NSW 2006, Australia; 2Department of Rehabilitation Sciences, 
Hong Kong Polytechnic University, Hung Hom, Kowloon, 
Hong Kong
Duchenne muscular dystrophy is a severe muscle wast-
ing disease caused by the absence of the cytoskeletal pro-
tein dystrophin. Experiments on the mdx mouse, which 
also lacks dystrophin, have shown that mdx muscles are 
particularly susceptible to stretch-induced damage. We 
have shown that Ca2+ entry through a channel blocked 
by streptomycin, Gd3+, or the spider venom peptide, 
GsMTx-4, contributes to stretch-induced muscle dam-
age (Yeung, E.W., N.P. Whitehead, T.M. Suchyna, 
P.A. Gottlieb, F. Sachs, and D.G. Allen. 2005 J. Physiol. 
562:367–380). The pharmacological and functional 
properties of this Ca2+ entry channel resemble a stretch-
activated channel permeable to many cations known 
as SACNSC, which is expressed in muscle and for which 
a candidate gene is TRPC1 (Maroto, R., A. Raso, T.G. 
Wood, A. Kurosky, B. Martinac, and O.P. Hamill. 2005. 
Nat. Cell Biol. 7:179–185). We have also shown that Ca2+ 
entry into mdx muscle fi  bers can also be stimulated by 
H2O2 and entry is also blocked by streptomycin, suggest-
ing that the physiological activator of SACNSC may be 
reactive oxygen species (ROS). To gain further under-
standing of the properties of TRPC1, it was expressed in 
C2 myoblasts. When expressed alone, it did not appear 
in the surface membrane, but when coexpressed with 
caveolin-3, the proteins co-located in the membrane 
(Gervásio, O.L., N.P. Whitehead, E.W. Yeung, W.D. Phil-
lips, and D.G. Allen. 2008. J. Cell Sci. 121:2246–2255). 
When TRPC1 was located in the membrane, it could be 
activated by H2O2, causing Ca2+ infl  ux that was blocked 
by PP2, an inhibitor of src kinase. These data suggest 
that in muscular dystrophy, excessive production of ROS 
might open SACNSC channels by activating src kinase. 
These pathways offer several new targets for therapy of 
muscular dystrophy.
22.  Displacement Currents and Voltage Dependency 
of Bi-stable Reversible Transitions in Molluscan Rho-
dopsin. MARÍA DEL PILAR GOMEZ1,3 and ENRICO 
NASI,2,3 1Departamento de Biología and 2Instituto de Gené-
tica, Universidad Nacional de Colombia, Bogotá; 3Marine Bio-
logical Laboratory, Woods Hole, MA 02543
The molecular rearrangement of rhodopsin upon 
photoisomerization is accompanied by a net charge 
displacement with a vectorial component normal to 
the membrane plane. As a result, a rapid early receptor 
current (ERC) is produced, which is easily detectable 
by voltage clamp recording when the photopigment 
is embedded in the plasmalemma. This signal allows, 
among others, separating the triggering events of the 
visual process from those arising from the subsequent 
activation of the enzymatic transduction pathway. We 
examined the ERC in the ciliary photoreceptors of 
the distal retina of Pecten, in which the photopigment 
is thermally stable, and transitions between rhodopsin 
(R) and metarhodopsin (M) states are accompanied by 
a marked shift in spectral absorbance; as such, revers-
ible manipulations of the pigment-state distribution 
can be induced by chromatic illumination. Delivery of 
brief, intense fl  ashes under voltage clamp induced dis-
placement currents that could be isolated by kinetics, by 
pharmacological blockage of the photoconductance, or   9a
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by elimination of the driving force on K ions that com-
prise the photocurrent. The polarity and amplitude of 
the displacement currents could be controlled by prior 
chromatic adaptation in which the wavelength of the 
adapting light was varied, while using fi  xed, spectrally 
neutral test stimuli. In particular, limiting initial distri-
butions yielded ERCs of opposite directions (concomi-
tant with M→R and R→M transitions, respectively), but 
conserved total charge. The occurrence of a charge dis-
placement necessarily implies that the conformational 
transition rates of the receptor molecule must interact 
with the membrane fi  eld. We recorded ERCs in both 
directions, while systematically varying the holding po-
tential of the cell by voltage clamp. A distinct, orderly 
dependency of the peak amplitude of the displacement 
current on membrane potential was obtained; this rela-
tion is analyzed in terms of energetics of rhodopsin con-
formational rearrangement and the equivalent charge 
implicated.
Supported by NSF grant 0639774.
23.  Extending the Sensitivity of Amperometric Re-
cording By Phase-Lock Measurements. MARÍA DEL 
PILAR GÓMEZ,1,4 JUAN MANUEL ANGUEYRA,2,4 and 
ENRICO NASI,3,4 1Departamento de Biología, 2Programa de 
Neurociencias, and 3Instituto de Genética, Universidad Na-
cional de Colombia, Bogotá; 4Marine Biological Laboratory, 
Woods Hole, MA 02543
Electrochemical detection of oxidizable compounds 
via microscopic fi  bers has been a valuable approach 
for examining secretion mechanisms, and, in its most 
ambitious applications, has allowed monitoring release 
at the single-cell level. Inevitably, owing to the minute 
amounts of the target substance, concentration changes 
in the vicinity of an individual, isolated cell are ex-
ceedingly small, and the sensitivity limit of the detect-
ing instrument is a severe limiting factor. This issue is 
particularly challenging for non-vesicular secretion, a 
non-canonical mechanism of signifi  cant interest: unlike 
exocytosis (where the molecules are released in batches 
of thousands), in this case extrusion occurs at a much 
slower rate, and the resulting extracellular concentra-
tion changes are even smaller, yielding a grossly inad-
equate signal-to-noise ratio. Phase-locked detection can 
bring out a small signal buried in a much larger noise, 
provided that the signal in question can be modulated 
with an established periodicity, which effectively accom-
plishes two goals: (1) displace the signal away from the 
DC end of the spectrum, where 1/f noise is dominant; 
(2) enable extraction of the signal by ultra-narrow band-
width fi  ltering. We developed a method in which the 
electrical potential of a carbon fi  ber is modulated sinu-
soidally, and  a dual phase/lock loop amplifi  er is used 
to extract the oxidation current from contaminating di-
electric signals of the same frequency that arise from the 
electrical double-layer at the electrode–solution inter-
face. The bandwidth of this approach is limited by the 
integration interval and thus by the driving frequency 
used. Initial measurements reveal that the detection 
limit attained exceeds that of conventional amperomet-
ric measurements with constant electrode polarization, 
while the temporal resolution is in the range of 101 s. 
This approach can thus be useful for point measure-
ments of changes in concentration of oxidizable sub-
stances released with fl  ux magnitudes and time course 
like those expected in transporter-mediated extrusion.
24.  Skeletal Muscle Impairment during Micrograv-
ity-induced Disuse: Benefi   cial Effects of Different 
Pharmacological Countermeasures. J.-F. DESAPHY,1 
A. LIANTONIO,1 S. PIERNO,1 C. DIGENNARO,1 V. 
CIPPONE,1 G. CAMERINO,1 V. GIANNUZZI,1 S. SI-
MONETTI,2 and D. CONTE CAMERINO,1  1Sezione di 
Farmacologia, Dip. Farmaco-biologico, Facoltà di Farmacia, 
Università degli Studi di Bari, 70124 Bari, Italy; 2Laboratorio 
Analisi, Diagnostica Biochimica Metabolica, Ospedale Gio-
vanni XXIII, 70126 Bari, Italy
Rodent hindlimb unloading (HU) is a widely ac-
cepted ground-based model of skeletal muscle adapta-
tion to microgravity or bed rest–induced disuse. After 
HU, soleus muscle, a slow-twitch muscle functionally 
devoted to postural maintenance, experience atrophy 
and slow-to-fast phenotype transition. In parallel, rest-
ing sarcolemma chloride conductance (gCl), which 
controls muscle excitability, and cytosolic calcium at rest 
(restCa) are modifi  ed by HU condition. Indeed, restCa, 
measured by FURA-2, decreased and gCl, measured by 
2-intracellular-microelectrode current clamp technique, 
increased after 3-day HU toward values typical of fast-
twitch muscle, before initiation of myosin heavy chain 
(MHC) transition. The gCl increase resulted from the 
reduction of protein kinase C activity (Pierno, S., J.F. 
Desaphy, A. Liantonio, A. De Luca, A. Zarrilli, L. Mas-
trofrancesco, G. Procino, G. Valenti, and D. Conte Cam-
erino. 2007. J. Physiol. 584:983–995). In soleus muscle of 
14-day HU rodents, the expression of fast MHC isoform 
was also found to be increased. Searching for potential 
candidates able to counteract muscle alterations, we 
tested drugs able to affect those parameters modifi  ed 
by HU. The aminoacid taurine is known to modulate 
both calcium homeostasis and gCl (Conte Camerino, 
D., D. Tricarico, S. Pierno, J.F. Desaphy, A. Liantonio, 
M. Pusch, R. Burdi, C. Camerino, B. Fraysse, and A. 
De Luca. 2004. Neurochem. Res. 29:135–142). A taurine-
enriched diet signifi  cantly prevented changes in gCl, 
restCa, and MHC expression, but not atrophy in HU 
rat soleus muscles. Recent data suggest a link between 
oxidative stress and muscle atrophy. Thus, we evaluate 
the effects of the treatment with the potent antioxidant 
trolox in HU mice. This compound fully prevented li-
poperoxidation, measured by fl  uorimetric  technique 
and gCl increase. However, trolox partially counteracted 10a
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MHC isoform transition, but had no effect on atrophy. 
The hormone ghrelin can improve lean body mass in 
catabolic states and reduces gCl in fast-twitch muscles 
through PKC activation. Preliminary experiments sug-
gest that ghrelin improves the modifi  cation of gCl in 
soleus muscle of 3–14-day HU mice. These results dem-
onstrate the benefi  cial effects of all these compounds in 
the prevention of HU-induced muscle impairment.
Supported by ASI-OSMA.
25.  Calcium, MAPKs, and Cardiac Hypertrophy. FAYE 
M. DRAWNEL1 and H. LLEWELYN RODERICK,1,2 1Labo-
ratory of Molecular Signaling, Babraham Institute, Cambridge 
CB22 3AT, England, UK; 2Department of Pharmacology, Uni-
versity of Cambridge, Cambridge CB2 1PD, England, UK
Pathological cardiac hypertrophy is a maladaptive re-
sponse of the myocardium to persistent cardiovascular 
stress. The cellular features observed during hypertrophy 
can be recapitulated on stimulation of cultured neona-
tal rat ventricular myocytes (NRVMs) with the paracrine 
modulator endothelin-1 (ET-1). Multiple signaling path-
ways are activated by ET-1 stimulation, including MAPK 
cascades and IP3-dependent calcium release.
Application of ET-1 (100 nM) to NRVM for 24 hours 
increased expression of the hypertrophic marker atrial 
natriuretic factor (ANF) at both the mRNA and pro-
tein level. The MEK1 inhibitor PD184352 (1 μM) in-
hibited the response to ET-1. This effect was observed 
both in the presence and absence of voltage-gated cal-
cium cycling. ET-1 also increased mRNA levels of dual 
specifi  city phosphatase 6 (DUSP6), a negative regulator 
of the ERK1/2 cascade. Overexpression of DUSP6 by 
adenoviral infection inhibited both basal and agonist-
induced ANF expression. The mechanism underlying 
ERK1/2-dependent gene expression was investigated by 
monitoring the activity of an AP-1–dependent luciferase 
reporter construct. Application of ET-1 increased AP-1 
luciferase activity in a PD184352-sensitive manner. To 
further characterize the signifi  cance of ERK1/2 signal-
ing, workload-induced hypertrophy was modeled by 
enhancing global calcium signals with BayK 8644, an 
L-type calcium channel agonist. Inhibition of ERK1/2 
prevented BayK 8644–induced hypertrophy. Intrigu-
ingly, BayK 8644 did not induce AP-1–dependent tran-
scriptional activity.
In summary, these results indicate that ERK1/2 activ-
ity is necessary for gene expression induced by multiple 
hypertrophic agonists. In the absence of global calcium 
signals, sensitivity to ERK1/2 inhibition persists. This 
suggests that ERK1/2 activity is necessary for the induc-
tion of hypertrophy-associated gene expression under 
conditions that solely elicit IP3-dependent calcium re-
lease, which is itself necessary for the hypertrophic re-
sponse. Although both ET-1 and BayK 8644 induce an 
ERK1/2-dependent hypertrophic pattern of gene ex-
pression, only ET-1 elicits AP-1 transcriptional activity. 
This implies that additional transcriptional regulators 
must be involved in the hypertrophic response.
26.  Calcium and Blood Flow Regulation. HÉLÈNE 
GIROUARD,1 ADRIAN D. BONEV,1 RACHAEL HAN-
NAH,1 ANDREA MEREDITH,2 RICHARD ALDRICH,3 
and  MARK T. NELSON,1  1Department of Pharmacology, 
University of Vermont, Burlington, VT 05405;  2Department 
of Physiology, University of Maryland, Baltimore, MD 21201; 
3Department of Neurobiology, University of Texas, Austin, TX 
78712
Functional hyperemia, a vasodilatory response to in-
creased neuronal activity, ensures an adequate supply of 
nutrients and oxygen to active brain regions. Increased 
intracerebral blood fl  ow in response to neuronal activity 
is a fundamental physiological process that is exploited 
diagnostically, forming the basis for techniques such as 
functional magnetic resonance imaging (fMRI), which 
uses both perfusion and blood oxygenation level–depen-
dent (BOLD) contrast to map brain function.
Recent evidence indicates that neuronal activity is en-
coded in astrocytes in the form of dynamic intracellular 
calcium (Ca2+) signals, which travel to astrocytic pro-
cesses (“endfeet”) encasing the arterioles in the brain. 
Astrocytic Ca2+ signaling has been implicated in the dila-
tory response of adjacent arterioles, in keeping with the 
functional linkage between neuronal activity and en-
hanced local blood fl  ow. Paradoxically, however, astro-
cytic Ca2+ signals have also been linked to constriction.
Here, we show that regardless of the mechanism by 
which astrocytic endfoot Ca2+ was elevated, modest in-
creases in Ca2+ induced dilation, whereas larger increases 
switched dilation to constriction. Large-conductance, 
Ca2+-sensitive potassium (BK) channels in astrocytic 
endfeet mediate a majority of the dilation and the en-
tire vasoconstriction, implicating local extracellular K+ 
as a vasoactive signal for both dilation and constriction. 
K+ effl  ux through astrocytic endfoot BK channels could 
lead to a rapid dilation or constriction of adjacent ar-
terioles, depending on its local perivascular concentra-
tion. Elevation of external K+ to 20 mM or less activates 
smooth muscle (SM) inward rectifi  er potassium chan-
nels, causing SM hyperpolarization, closing of SM 
voltage-dependent calcium channels, a decrease in SM 
calcium, and thereby vasodilation. Elevation of external 
K+ above 20 mM causes SM depolarization and vasocon-
striction. These results provide evidence for a unifying 
mechanism that explains the nature and apparent du-
ality of the vascular response, showing that the degree 
and polarity of neurovascular coupling depends on ex-
tracellular K+ and astrocytic endfoot Ca2+.
27.  The Rapid Actions of Anabolic-Androgenic Ste-
roids (AAS) Are Mediated through the Epidermal 
Growth Factor Receptor (EGFR). M.M. HAMDI and G. 
MUTUNGI, Biomedical and Clinical Sciences Research Insti-  11a
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tute, School of Medicine, Health Policy and Practice, Univer-
sity of East Anglia, NR4 7TJ Norwich, England, UK
It is now generally believed that anabolic-androgenic 
steroids (AAS) have both genomic and nongenomic 
actions (Lösel, R.M., E. Falkenstein, M. Feuring, A. 
Schultz, H-.C. Tillmann, K. Rossol-Haseroth, and M. We-
hling. 2003. Physiol. Rev. 83:965–1016). The genomic ac-
tions of AAS take several hours to days to be manifested 
and are mediated through the androgen receptor, a 
member of the nuclear receptor family (Heinlein, C.A., 
and C. Chang. 2002. Mol. Endocrinol. 16:2181–2187). In 
contrast, the rapid actions of AAS are evident within 
minutes and may be effected through second messen-
ger signaling mechanisms initiated by the attachment of 
these hormones to a G protein–coupled receptor on the 
cell surface (Estrada, M., A. Espinosa, M. Muller, and 
E. Jaimovich. 2003. Endocrinology. 144:3586–3597). How-
ever, the receptor involved remains uncertain. There-
fore, the primary aim of this study was to investigate the 
identity of this receptor.
The experiments were performed using small muscle 
fi  ber bundles isolated from either the extensor digito-
rum longus (a fast-twitch muscle) or soleus (a slow-twitch 
muscle) of adult female CD-1 mice aged 49 ± 5 days. The 
fi  ber bundles were treated with DHT, DHT plus various 
inhibitors, or the vehicle only. During an experiment, 
maximum isometric tension (Po) was measured and the 
fi  ber bundles were processed for immunoblotting.
Our results show that treating the fi  ber bundles with 
DHT increased Po in fast-twitch fi  bers but decreased it 
in the slow-twitch fi  bers. It also led to a two- to threefold 
increase in the phosphorylation of extracellular signal–
activated kinases 1/2 and the 20-kD regulatory myosin 
light chains in both fi  ber types. Moreover, all these ef-
fects could be reversibly blocked by AG1478 but not by 
fl  utamide and cyproterone acetate. From these results, 
we suggest that DHT exerts its rapid actions, in intact 
mammalian skeletal muscle fi  bers, through the EGFR.
28.  Investigating the Putative Role in Muscle Hyper-
trophy of the Novel Skeletal Muscle–specifi  c Protein 
IGFN1. ANDREW HAYNES, JANE BAKER, GENNA 
RILEY, and GONZALO BLANCO, Mammalian Genetics 
Unit, MRC Harwell, Science and Innovation Campus, Ox-
fordshire OX11 0RD, England, UK
KY is a 72-kD protein that underlies the ky-kyphoscoli-
otic muscular dystrophy in the mouse (Blanco, G., G.R. 
Coulton, A. Biggin, C. Grainge, J. Moss, M. Barrett, A. 
Berquin, G. Maréchal, M. Skynner, P. van Mier, et al. 
2001.  Hum. Mol. Genet. 10:9–16). A yeast two-hybrid 
(Y2H) screen with KY as bait revealed interactions with 
several sarcomeric proteins, including fi  lamin C and a 
fragment of a novel protein provisionally named KYIP1 
(KY-interacting protein 1) (Beatham, J., R. Romero, S.K. 
Townsend, T. Hacker, P.F. van der Ven, and G. Blanco. 
2004. Hum. Mol. Genet. 13:2863–2874), now renamed 
IGFN1 (immunoglobulin and fi  bronectin 3–containing 
protein 1). Our analysis revealed that Igfn1 is a complex 
locus conserved in all available mammalian genomes. 
Encoded here are IGFN1, a large skeletal muscle-spe-
cifi   c protein, and other smaller isoforms showing a 
wider expression profi  le. IGFN1 contains two segments 
spanning three and eight globular domains located at 
the N and C termini of the protein, respectively, and 
separated by a large unstructured region lacking any 
recognizable domain. Y2H, biochemical, and immuno-
fl  uorescence experiments have provided evidence that 
IGFN1, KY, and FLNC are members of a protein com-
plex that localize to the sarcomeric Z-band. However, 
in adult skeletal muscle IGFN1 behaves as a Z-band–
associated protein that is also present in the nucleus. 
Here, we show that the three N-terminal globular do-
mains of IGFN1 are suffi  cient to provide both nuclear 
localization and Z-band targeting in transduced cardio-
myocytes and transgenic lines. Consistent with those 
observations, IGFN1 immunohistochemistry of adult 
muscle shows clear Z-band staining as well as nuclear 
staining in a proportion of myonuclei. However, atro-
phic muscles in the ky/ky mouse mutant, such as so-
leus, do not show IGFN1 staining in the nucleus. We 
hypothesize that the Z-band KY protein complex could 
be involved in mediating a response to changes in ten-
sion or overload, and that IGFN1 could act as a link to 
the nucleus to infl  uence transcriptional changes. This 
hypothesis is being tested using mouse transgenic and 
in vitro models.
29.  A Mutation Associated with DCM Increases Phos-
pholamban (PLB) Oligomerization and Decreases 
SERCA Binding, but Does Not Change PLB Tertiary 
Structure or Phosphorylation by PKA. ZHANJIA HOU,1 
RAFFAELLO VERARDI,2 LARRY R. MASTERSON,2 
NAOMI MENARDS,2 KIM N. HA,2 ALESSANDRO MAS-
CIONI,2 GIANLUIGI VEGLIA,2 and SETH L. ROBIA,1 
1Loyola University Chicago, Maywood, IL 60153; 2University 
of Minnesota, Minneapolis, MN 55455
To better understand the pathological mechanism 
of a human dilated cardiomyopathy phospholamban 
(PLB) mutation (R9C), we investigated the effects of 
this mutation on PLB structure and regulatory inter-
actions. Notably, we observed effi  cient  phosphoryla-
tion of R9C-PLB by PKA in vitro, and nuclear magnetic 
resonance (NMR) spectroscopy showed no change in 
R9C-PLB structure compared with WT. However, R9C-
PLB reconstituted into lipid vesicles showed increased 
sensitivity to oxidizing conditions, responding to per-
oxide challenge with a decreased electrophoretic mo-
bility suggestive of increased oligomerization. This 
oligomeric species was characterized by a high thermal 
stability compared with WT pentamers. To test R9C-PLB 
binding interactions in live cells, PLB was expressed as 
cyan and yellow fl  uorescent protein (CFP/YFP) fusions 12a
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in AAV-293 cells, and PLB oligomerization and SERCA 
binding were quantifi  ed by fl  uorescence resonance en-
ergy transfer (FRET). 100 μM H2O2 applied to the cells 
induced a rapid quench of CFP-R9C-PLB fl  uorescence 
and a concomitant increase in YFP-R9C-PLB fl  uores-
cence, indicating an increase in intraoligomeric FRET 
after oxidation. FRET enhancement after peroxide 
addition was not observed for CFP/YFP-WT-PLB. To 
test whether the FRET increase was due to increased 
oligomerization or a quaternary conformation change, 
we measured intraoligomeric FRET in a population 
of cells expressing a wide range of R9C-PLB protein 
concentrations. FRET dependence on concentration 
yielded oligomer-intrinsic FRET effi  ciency (FRETmax) 
and relative dissociation constant (KD). Compared 
with WT, R9C-PLB had a decreased KD and increased 
FRETmax, indicating an increased oligomerization af-
fi  nity and more compact oligomer structure, respec-
tively. The enhanced oligomerization of R9C-PLB was 
matched by a decrease in SERCA binding compared 
with WT. Overall, the data suggest a new mechanism 
by which the R9C mutation may exert a pathological 
effect: decreased SERCA regulation and increased oli-
gomerization, as consequences of increased oxidation 
sensitivity of R9C-PLB.
30.  FRET Microscopy Reveals that PLB Binds More 
Avidly to SERCA1a than SERCA2a. ZHANJIA HOU and 
SETH L. ROBIA, Department of Physiology, Loyola Univer-
sity Chicago, Maywood, IL 60153
Phospholamban is expressed at high levels in the 
heart, where it is the major regulator of the calcium 
pump SERCA2a. However, it is also present at lower lev-
els in skeletal muscle, where both SERCA1a and SER-
CA2a variants are present. These SERCA isoforms have 
been used interchangeably in mutagenic and structural 
analyses of the PLB-SERCA interaction, since in vitro 
studies have shown their functional inhibition by PLB 
is equivalent. To quantify the quaternary structure and 
binding energetics of PLB binding to SERCA isoforms, 
Förster resonance energy transfer (FRET) from CFP-
SERCA1a or CFP-SERCA2a to YFP-PLB was measured 
in live AAV-293 cells. FRET effi  ciency increased with 
increasing protein expression level to a maximum of 
28.8% for PLB-SERCA1a and 28.1% for PLB-SERCA2a, 
suggesting that the complexes have the same quater-
nary conformation. Unexpectedly, the data also re-
vealed that PLB has a 2.6-fold higher apparent affi  nity 
for SERCA1a relative to SERCA2a. To test whether the 
observed difference in affi  nity arises from differential 
distributions of SERCA E1/E2 enzymatic substates, cells 
were treated with 1 mM EGTA and 0.5 uL/ml calcium 
ionophore A23187. Under these conditions, PLB still 
showed greater affi  nity for SERCA1a over SERCA2a, 
suggesting that the differential affi  nities are intrinsic 
properties of the SERCA isoforms. The data suggest 
that PLB preferentially binds SERCA1a over SERCA2a, 
a selectivity that may be functionally signifi  cant in skel-
etal muscle.
31.  Modeling the Intramuscular Signals that Regulate 
Muscle Protein Degradation. LEWIS A. JACOBSON1 
and NATHANIEL J. SZEWCZYK,2 1Department of Biologi-
cal Sciences, University of Pittsburgh, Pittsburgh, PA 15260; 
2University of Nottingham, School of Graduate Entry Medicine 
and Health, Derby City General Hospital, Derby DE22 3DT, 
England, UK
Muscle protein degradation is associated with a vari-
ety of human diseases and is thought to be regulated by 
at least a dozen extra-muscular signals. We have spent 
several years developing C. elegans, a genomic model 
organism, into a model for studying the intramuscular 
signals that regulate cytosolic muscle protein degrada-
tion. As of April 1, 2009, we have examined 324 genes 
(of roughly 20,000 total or 3,000 muscle enriched) by 
mutation and/or RNAi and have found 64 genes that 
regulate muscle protein synthesis and/or degradation. 
We have discovered that: (1) proteasome-mediated deg-
radation is negatively regulated by genes that regulate 
depolarization of the plasma membrane and intra-mus-
cular calcium release; (2) autophagy-mediated degra-
dation is combinatorially regulated by negative signal 
from insulin and TGF- receptors and positive signal 
from a constitutive, autocrine FGF signal; (3) apparent 
calpain-mediated degradation is negatively regulated by 
a variety of integrin-linked molecules at the costamere; 
(4) as many as 20% of kinases (100 of 450 have been 
tested) and 30% of genes that regulate muscle contrac-
tion (105 of 2,000 have been tested) may act to regu-
late cytosolic muscle protein degradation. In so far as 
they have yet been examined, identical signals appear 
to function in mammalian muscle. Although the regu-
latory network controlling muscle protein degradation 
in human beings likely involves additional components, 
connections, and thus complexity, C. elegans appears 
to be a good model for understanding the evolution-
arily conserved elements that regulate muscle protein 
degradation.
1,2NIH NIAMS R01AR054342; 1NSF MCB-0542355; 
and 2MRC G0801271.
32. Specifi  c Pattern of Ionic Channel Gene Expression 
Associated with Proliferation of Vascular Smooth Muscle 
Cells. JOSÉ RAMÓN LÓPEZ-LÓPEZ,1 PILAR CIDAD,1 
ALEJANDRO MORENO-DOMÍNGUEZ,1 LAURA NO-
VENSÁ,2 MERCÉ ROQUÉ,2 MAGDA HERAS,2 and M. 
TERESA PÉREZ-GARCÍA,1 1Departamento de Bioquímica y 
Biología Molecular y Fisiología e Instituto de Biología y Gené-
tica Molecular (IBGM), Universidad de Valladolid y CSIC, 
47003 Valladolid, Spain;  2Servicio de Cardiología. Institut 
Clinic del Tòrax, Hospital Clinic, IDIBAPS, Universidad de 
Barcelona, 08007 Barcelona, Spain  13a
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Vascular smooth muscle cells (VSMCs) regulate ves-
sel diameter and determine tissue perfusion. However, 
they also contribute signifi  cantly to occlusive vascular 
diseases by virtue of its ability to switch to an activated, 
noncontractile, migratory, and proliferating pheno-
type. Although the participation of ion channels in this 
phenotypic switch has been previously described, the 
changes in their expression are poorly defi  ned mainly 
due to their large molecular diversity. Here, we used 
high-throughput real-time PCR to obtain a global por-
trait of ion channel expression in contractile VSMCs 
from mouse femoral arteries, exploring changes upon 
phenotypic switch in two experimental paradigms: an 
in vivo model of endoluminal lesion–induced neointi-
mal hyperplasia and an in vitro model in which cultured 
VSMCs were obtained from explants. The channel genes 
studied included K+ channels (, , and  subunits) and 
 subunits of voltage-dependent Ca2+ channels (VDCC), 
Cl, and TRP channels. The analysis of changes in mRNA 
expression of these channels showed a good correlation 
between the two proliferative models, with 16 genes dis-
playing signifi  cant variation in both conditions. Among 
those, only two genes, Kv1.3 and Kv2, increased their 
expression in proliferative VSMCs. By combining immu-
nological and electrophysiological techniques, we ex-
plore the expression and the functional contribution of 
these proteins in contractile and proliferating VSMCs. 
Our data show that Kv1.3 currents become the predom-
inant outward K+ current in cultured VSMCs. Moreover, 
we found that the up-regulation of Kv1.3 currents in 
these cells is an essential component of the phenotypic 
switch, as the specifi  c blockade of Kv1.3 channels inhib-
its VSMCs migration and proliferation. Collectively, our 
results pinpoint Kv1.3 channels as new therapeutical 
targets for the treatment of vascular disorders involving 
VSMC proliferation.
Supported by Heracles network (grant R006/009), 
Spanish Department of Science (grant BFU2007-61524), 
and Junta de Castilla y León (grant GR242).
33.  The TRPP Channel PKD1L2 Is Linked with a 
Complex Neuromuscular Disease in the Mouse. FRAN-
CESCA E. MACKENZIE, ROSARIO ROMERO, DEB-
BIE WILLIAMS, HELEN HILTON, TERTIUS HOUGH, 
LINDA GREENSMITH, RICHARD R. RIBCHESTER, 
and GONZALO BLANCO, MRC Mammalian Genetics 
Unit, Harwell OX11 0RD, England, UK
Ostes is a novel N-ethyl N-nitrosourea (ENU)-induced 
mouse mutant with muscle atrophy. Ostes mice suffer 
chronic neuromuscular impairments, including neu-
romuscular junction degeneration, polyneuronal in-
nervation, and myopathy. Analysis of 23 other tissues, 
including heart, did not reveal any other pathological 
change. Genetic mapping identifi  ed a small region on 
distal chromosome 8 segregating with the ostes pheno-
type. Sequence analysis of that chromosomal segment 
revealed no coding or splicing mutation in any of the 
annotated genes. However, expression studies indicated 
accumulation of the protein PKD1L2 in skeletal muscle 
from ostes/ostes mice. Because the mutation provoking 
up-regulation of the linked gene Pkd1l2 has not yet been 
identifi  ed, we tested the hypothesis that overexpression 
of this gene is causative by generating a transgenic line 
with a BAC clone spanning Pkd1l2 and one fl  anking 
gene on each side. The fl  anking genes, Gcsh and Bcmo1, 
were ruled out as candidates for this disease, as their ex-
pression was normal in ostes/ostes mice and their exons 
and cDNAs contained no mutation. Transgenic mice 
Tg(Pkd1l2)/Tg(Pkd1l2) reproduced the ostes myopathic 
changes, including fi  ber size asymmetry, small but sig-
nifi  cant reduction of the cross-sectional area of type II 
fi  bers, regeneration, and lack of macrophage infi  ltra-
tion. Muscle atrophy in Tg(Pkd1l2)/Tg(Pkd1l2) mice was 
more severe than in ostes/ostes mice. Moreover, double 
heterozygous mice (ostes/+, Tg(Pkd1l2)/0) suffer myo-
pathic changes more profound than each heterozygote, 
indicating positive correlation between PKD1L2 levels 
and disease severity. We show that, in vivo, PKD1L2 pri-
marily associates with endogenous fatty acid synthase 
(FASN) in normal skeletal muscle, and these proteins 
appear to colocalize to costameric regions of the mus-
cle fi  ber. In diseased ostes/ostes muscle, both proteins are 
up-regulated and ostes/ostes mice show signs of abnormal 
lipid metabolism. In conclusion, our data suggest that 
PKD1L2 up-regulation is a cause of neuromuscular de-
fects in mice.
34.  A New Molecular Mechanism for Familial Dilated 
Cardiomyopathy Based on Studies with Intact Mutant 
Transgenic Mouse and Human Explanted Heart Mus-
cle. STEVEN B. MARSTON, EMMA C. DYER, ADAM M. 
JACQUES, ANDREW E. MESSER, DOMINIC WELLS, 
and WEIHUA SONG, Imperial College London, London 
SW7 2AZ, England, UK
Familial dilated cardiomyopathy (DCM) can be caused 
by mutations in sarcomeric proteins. Studies of DCM 
mutations in TnT, TnC, and tropomyosin in recombi-
nant protein in vitro indicated a common molecular 
phenotype with reduced Ca2+ sensitivity and cross-bridge 
cycling rate. However, investigations in more organized 
systems contradict this mechanism, putting its physi-
ological relevance in doubt.
We investigated native thin fi  lament Ca2+-regulatory 
properties using actin from a transgenic mouse express-
ing the E361G DCM-causing mutation combined with 
human cardiac troponin and tropomyosin.
In in vitro motility assays (IVMAs) we could observe 
no differences between E361G and NTG mouse thin fi  l-
aments; however, when troponin was dephosphorylated 
with acid phosphatase, we observed that E361 Ca2+ sen-
sitivity was lower than NTG, as previously found with the 
recombinant proteins (ratio of EC50 1:2.6). When we 14a
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compared natively phosphorylated and dephosphory-
lated thin fi  laments, we observed that Ca2+ sensitivity did 
not change in E361G mouse thin fi  laments, but the Ca2+ 
sensitivity increased 3.1 times on dephosphorylation of 
NTG mouse as expected. Thus, the only functional 
change induced by the E361G mutation in cardiac actin 
was a blunted response to troponin I phosphorylation. 
This would be predicted to compromise the lusitropic 
response to catecholamines.
In addition, we studied troponin extracted from the 
explanted heart of a DCM patient carrying the cardiac 
TnC G159D mutation. IVMA investigation of recon-
stituted thin fi  laments showed that the cTnC G159D 
mutation also showed little change in Ca2+ sensitivity 
when TnI was dephosphorylated (EC50 P/unP = 1.2 ± 
0.2). TnC G159D troponin also showed a higher Ca2+ 
sensitivity than donor heart troponin, regardless of 
phosphorylation status.
We propose that the DCM phenotype is caused by un-
coupling of the relationship between phosphorylation 
and Ca2+ sensitivity. Ca2+ sensitivity is not correlated with 
DCM, but the phosphorylation status of troponin I and 
other posttranslational modifi  cations of sarcomeric pro-
teins are critical determinants of the functional effects 
of a mutation.
35.  Pump Dysfunction and Depressed Contractile Re-
serve in a Murine Model of Hypertrophic Cardiomyopa-
thy. RICHARD L. MOSS and CARL TONG, Department 
of Physiology, University of Wisconsin School of Medicine and 
Public Health, Madison, WI 53705
Heritable hypertrophic cardiomyopathies (HCMs) are 
the most common cause of unexpected sudden death in 
the young and are due in most cases to a point mutation 
in one of several sarcomeric proteins, including  myo-
sin heavy chain, myosin binding protein C, and regula-
tory proteins associated with the thin fi  lament. HCMs 
are characterized by accelerated contraction during sys-
tole, but cardiac function is paradoxically reduced. To 
study the basis for these phenomena, we have developed 
a murine model of hypertrophic cardiomyopathy due 
to disruption of the MYBPC3 gene that encodes cardiac 
myosin binding protein C (cMyBP-C), a thick fi  lament 
accessory protein that is thought to have both structural 
and regulatory roles in striated muscle contraction. This 
disruption of the gene results in ablation of cMyBP-C, 
which is similar to the molecular phenotype observed 
in human patients with HCM due to C-terminal trunca-
tions of cMyBP-C in which sarcomeric cMyBP-C content 
is reduced. Hearts from these mice exhibit septal hy-
pertrophy, increased chamber size, and reductions in 
both stroke volume and the period of ejection. Myocar-
dium from these mice exhibit depressed twitch force–
frequency relationships, accelerated relaxation kinetics, 
and a loss of both frequency-dependent and  agonist–
induced acceleration of relaxation. These results can be 
explained by an acceleration of cross-bridge interaction 
kinetics due to the ablation of cMyBP-C, which in turn 
cause an acceleration of twitch kinetics, a reduction in 
peak force or pressure, and reduced stroke volume.
36.  Cardiomyocytes from Human Embryonic Stem 
Cells. CHRISTINE MUMMERY, Department of Anatomy 
and Embryology, Leiden University Medical Centre, 2300 RC 
Leiden, Netherlands
Stem cells and development
Derivation of heart cells from human embryonic stem 
cells (HESCs) and understanding the underlying de-
velopmental mechanisms is the main focus of the re-
search. Culture conditions have now been suffi  ciently 
refi  ned so that cardiomyocyte differentiation is an ef-
fi  cient and reproducible process. Microarray analysis of 
modulations in gene expression during differentiation 
has shown that the major known cardiac genes are up-
regulated but that novel genes are also expressed.
Genetically marked HESCs have been produced 
in which expression of the green fl  uorescent protein 
marker is retained after differentiation. This has permit-
ted unambiguous tracing of cardiomyocytes after trans-
plantation into a mouse heart. Long-term survival of 
the cells and integration into the host heart have been 
observed, and the ability of these cells to restore cardiac 
function in mice that have undergone myocardial in-
farction is being investigated. More immediate applica-
tions of HESC-derived cardiomyocytes are being sought 
in drug discovery and disease.
37.  Exploring the Role of IGFN1 Variants in Cardiac Mus-
cle. GENNA RILEY, JANE BAKER, ROSARIO ROMERO, 
HELEN HILTON, and GONZALO BLANCO, Mamma-
lian Genetics Unit, MRC Harwell, Oxfordshire OX11 0RD, 
England, UK
A fragment of the novel protein, IGFN1, was identi-
fi  ed as an interacting partner of the sarcomeric pro-
tein, KY, the loss of which underlies a form of postural 
muscle-specifi   c muscular dystrophy in the mouse 
(kyphoscoliotic mutant). IGFN1 has a predicted domain 
composition comparable to that of other sarcomeric 
support proteins, including fi  lamin C, myosin binding 
protein C, and titin. Disruption within these genes is 
recognized as being associated with muscular dystro-
phies and cardiomyopathies. Hence, it was postulated 
that IGFN1 may also contribute to the degenerative 
molecular pathways common to these striated muscle-
specifi  c diseases.
In this work, northern analysis revealed that GEN-
SCAN predicted Igfn1, which is not expressed in the 
heart but is exclusively expressed in skeletal muscle, 
with smaller isoforms expressed in both tissues. These 
fi  ndings are substantiated by Western blot analysis us-
ing isoform-specifi  c antibodies. Several proteins have   15a
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been identifi   ed in heart extracts as putative IGFN1 
products with molecular weights of 189, 135, and 64 kD, 
with the 135-kD isoform being the most predominantly 
expressed form. Immunofl  uorescent analysis of heart 
cryosections and primary cultured murine cardiomyo-
cytes using antibodies raised against the C terminus of 
IGFN1 produced prominent intercalated disk staining. 
Ultrastructural analysis refi  ned this localization to the 
adherens junction. Furthermore, peptide mass fi  nger-
print analysis and liquid chromatography followed by 
tandem mass spectroscopy of IGFN1-immunoprecipi-
tated complexes identifi  ed N-cadherin, -catenin, and 
plakoglobin, three well-characterized proteins of the 
adherens junction, as interacting partners of the 135-kD 
IGFN1 variant. Collectively, this work tentatively suggests 
that cardiac IGFN1 is a newly identifi  ed structural com-
ponent of this specialized junction. To validate these re-
sults, cloning and expression of the major heart-specifi  c 
isoform in primary cardiomyocytes are currently being 
undertaken.
38.  Mouse HCM Model Expression E99K ACTC 
Mutation Reproduces the Clinical HCM Phenotype. 
WEIHUA SONG,1 DANIEL J. STUCKEY,2 EMMA 
DYER,1 DOMINIC WELLS,1 SIAN E. HARDING,1 
CAROLYN A. CARR,2 KIERAN CLARKE,2 and STE-
VEN B. MARSTON,1 1Imperial College London, London 
SW7 2AZ, England, UK; 2Oxford University, Oxford OX1 
2JD, England, UK
The mutation Gly99lys (E99K) in the cardiac actin 
(ACTC) gene causes hypertrophic cardiomyopathy 
(HCM). Transgenic (TG) mice expressing 50% E99K 
mutant cardiac actin in their hearts were generated and 
studied. Over 30% male and 70% female E99K mice 
died between 28 and 45 days just after adolescence.
We studied mutant actin from the survivors by in vitro 
motility assay. Thin fi  laments were reconstituted with 
purifi  ed mouse f-actin and human heart tropomyosin 
and troponin. The E99K thin fi  laments were 2.5 ± 0.6 
times more Ca2+ sensitive than NTG thin fi  laments 
(P = 0.05). E99K actin thin fi  laments also exhibited a 
reduced response to troponin dephosphorylation.
Isofl  uorane-anesthetized 7 month-old male TG mice 
(n = 9) and their NTG littermates (n = 7) were studied 
using in vivo cine MRI. Abnormal cardiac morphology 
and signifi  cantly lower ejection fractions (P = 0.01) and 
reduced stroke volumes (P < 0.001) were observed in 
the TG mice. Peak LV ejection rates were reduced 
(P = 0.01).
Left ventricle function of 9 month-old female NTG 
(n = 4) and TG (n = 5) mice were studied with an in vivo 
conductance catheter through apex after an anterior 
thoracotomy under isofl  urane. The TG mice had signif-
icantly reduced ejection fraction (P = 0.01), increased 
end-diastolic pressure (P = 0.02), and impaired relax-
ation (Tau_g, P = 0.003). LV dilation has been observed 
in these mice (end-systolic volume, P < 0.0001; end dia-
stolic volume, P = 0.04).
The ACTC E99K mouse reproduces many features of 
HCM as observed in patients: sudden death, partial pen-
etrance, impaired relaxation, asymmetrical and apical 
hypertrophy, and progression toward a dilated failing 
heart. The basic effect of the ACTC E99K mutation is in-
creased Ca2+ sensitivity together with a blunted response 
to troponin I phosphorylation.
The increased myofi  brilar Ca2+ sensitivity may be suffi  -
cient to provoke arrhythmia in E99K mice and account 
for the high mortality at early ages. Hypertrophy may 
be a chronic response to Ca2+ overloading or be due to 
energy depletion.
39.  Role of the Calcineurin (CnA)/NFAT Pathway in 
Pathological and Physiological Forms of Cardiac Myo-
cyte Hypertrophy. AMARNATH TALASILA,1 MARTIN 
D. BOOTMAN,1 and H. LLEWELYN RODERICK,1,2 
1Laboratory of Molecular Signaling, Babraham Institute, 
Cambridge CB22 3AT, England, UK; 2Department of Phar-
macology, University of Cambridge, Cambridge CB2 1PD, 
England, UK
We have recently shown that induction of pathologi-
cal cardiac hypertrophy by endothelin-1 (ET-1) is de-
pendent on activation of the CnA/NFAT pathway by 
InsP3-induced Ca2+ release (IICR) in the nucleus. Al-
though the requirement of the CnA/NFAT pathway in 
pathological hypertrophy is established, whether it has 
a role in physiological hypertrophy is debated. Here, 
we tested the hypothesis that IICR-mediated activation 
of the CnA/NFAT pathway acts as a molecular switch 
to determine the nature of the hypertrophic response 
(physiological vs. pathological).
Experiments were performed in neonatal rat ventric-
ular myocytes. Insulin-like growth factor-1 (IGF-1) was 
used to stimulate physiological hypertrophy and ET-1 to 
induce pathological hypertrophy. Hypertrophy was as-
sessed by real-time PCR analysis of mRNA levels of the 
hypertrophy markers atrial natriuretic factor (ANF), 
brain natriuretic peptide (BNP), and -skeletal actin 
(-SKA), and by measuring protein synthesis by [3H]-
leucine incorporation.
IGF-1 signifi  cantly increased the mRNA level of -SKA 
and protein synthesis, but unlike ET-1, it did not induce 
ANF and BNP. In these beating myocytes, inhibition of 
CnA activity with cyclosporin A prevented the action 
of IGF without affecting that of ET-1. The activity of an 
NFAT luciferase reporter (NFAT-luc) was signifi  cantly 
increased by both ET-1 and IGF-1. Inhibition of IICR 
by expression of InsP3 5 -phosphatase abolished the 
activation of the NFAT-luc by both hypertrophic me-
diators. Under conditions where excitation-contraction 
coupling (ECC)-associated Ca2+ transients were blocked 
with nifedipine and mibefradil, NFAT-luc activity was 
sensitive only to InsP3 5 -phosphatase upon ET-1 16a
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stimulation. In ECC-blocked cells, both ET-1 and IGF-1 
caused an increase in protein synthesis, but only after 
ET-1 stimulation was IICR dependent.
These data show that the CnA/NFAT pathway is ac-
tivated by IICR after stimulation with the inducers of 
both physiological and pathological hypertrophy. Our 
data may also suggest that a background of global ECC-
associated Ca2+ signals is required for the induction of 
physiological hypertrophy by IICR-mediated activation 
of NFAT.
40.  Myostatin Inhibits Calcium-dependent Signaling 
Pathways Activated by IGF-1 in Myoblast. JUAN AN-
TONIO VALDÉS and ALFREDO MOLINA, Facultad de 
Ecología y Recursos naturales, Universidad Andrés Bello, San-
tiago, Chile
The myogenic program involves several coordinated 
steps (myoblast proliferation, differentiation, and fu-
sion) regulated by extracellular cues, like myostatin and 
insulin-like growth factor-1 (IGF-1). IGF-1 is a positive 
regulator in proliferation and differentiation of skel-
etal muscle cells, whereas myostatin acts as a negative 
regulator of skeletal muscle mass. Both growth factors 
have potential application in the biomedical fi  eld. IGF-1 
expression in muscle ameliorates tissue deterioration 
caused by diverse myopathies; meanwhile, the inhibi-
tion of myostatin signaling pathways holds great prom-
ise for the treatment of muscle-wasting diseases.
These growth factors exert their antagonist functions, 
activating different transduction pathways mediated by 
their receptors. Myostatin has been shown to bind to 
activin type II receptors (serine/threonine kinase re-
ceptor family), activating a signal transduction pathway 
that leads phosphorylation of the transcriptions factors 
Smad2/Smad3, which ultimately leads to suppression 
of myogenesis. On the other hand, almost all biological 
actions of IGF-1 are mediated by binding to the IGF-1 
receptor (tyrosine kinase receptor family), activating 
transduction pathways mediated by phosphoinositide 
3-kinase (PI3K) related to muscle proliferation, differ-
entiation, protein synthesis, and hypertrophy.
However, recently experimental data obtained by our 
group and others strongly suggest a negative feedback 
through a cross talk between IGF-1 and myostatin sig-
naling pathways during myogenesis. Using myoblast of 
skeletal muscle primary culture, we found that IGF-1 
induces myostatin mRNA expression through the acti-
vation of signaling pathways PI3K and calcineurin de-
pendent, probably mediated by the transcription factor 
NFAT. In addition, myostatin inhibits calcium release 
induced by IGF-1 in myoblast and the activation of 
the transduction pathways PI3K-PLC- IP3-calcineurin-
NFAT. Considering these fi  ndings, we propose that dur-
ing myoblast differentiation, IGF-1 regulates myostatin 
gene expression and, in contrast, myostatin inhibits the 
IGF-1 signaling pathways. The information obtained in 
this project will contribute to the knowledge in the fi  eld 
of muscle development and will help us to understand 
unexplored areas in signal transduction with potential 
applications in biomedicine.
41.  Spatial Control of pHi in the Heart, and Its In-
fl   uence on the Local Control of Intracellular Ca2+ 
Signaling. RICHARD D. VAUGHAN-JONES,1 PAWEL 
SWIETACH,1 and KENNETH W. SPITZER,2  1Burdon 
Sanderson Cardiac Science Centre, Oxford OX1 3PT, Eng-
land, UK;  2Nora Eccles Harrison Cardiovascular Research 
and Training Institute (CVRTI), Salt Lake City, UT 84112
H+ ions and CO2 are metabolic end products that 
must be removed from respiring cells if intracellular 
pH is to be maintained at its normal value of 7.2. In 
the heart, CO2 is vented diffusively across a myocyte’s 
sarcolemma to the nearest capillary. In contrast, H+ ions 
are extruded on specifi  c ion transporters such as Na/H 
exchange (NHE1), or neutralized by HCO3
 ions im-
ported on sarcolemmal Na-HCO3 cotransport (NBC). 
Any spatial non-uniformity of pHi is minimized by high-
capacity cytoplasmic shuttling of H+ ions on histidyl di-
peptides such as carnosine and homocarnosine, which, 
because they are mobile buffers, can diffusively disperse 
H+ ions. Intracellular H+ dispersion also occurs, but to 
a lesser extent, on the CO2/HCO3 buffer system. These 
intracellular shuttles extend between adjacent myo-
cytes, through connexin channels at gap junctions. The 
channels appear to be both activated and inactivated 
by H+ ions so that, depending on the severity of a lo-
cal acidosis, they are either opened or closed to H+ ion 
shuttling. Gap junctions therefore provide a local pH-
gated control system for the spatial regulation of pHi 
in the myocardium. Spatial control of pHi may also 
be provided by exofacial carbonic anhydrase enzymes 
(CAs), which can facilitate CO2 venting from cells, 
thereby reducing the tendency of aerobic respiration to 
reduce pHi. The mechanism of spatial pHi regulation 
by connexins and CAs will be explored in the lecture. 
The effect of local pHi regulation on the spatial control 
of systolic and diastolic Ca2+
i will also be assessed. It ap-
pears that, in ventricular myocytes, intracellular organ-
elles and sarcolemmal pHi regulatory transporters are 
intimately involved in the local control of Ca2+ signal-
ing. Intracellular pH is thus a major spatial controller of 
Ca2+
i in the heart. Such spatial control of Ca2+
i will thus 
be disrupted during events such as regional myocardial 
ischaemia, which is associated with a failure of the local 
pHi control system.
42.  The Physiology and Pathophysiology of Uter-
ine Smooth Muscle. SUSAN WRAY, SARAH ARROW-
SMITH, KAREN NOBLE, AMANDA HEATH, SIOBHAN 
QUENBY, and THEODOR BURDYGA, Physiology Depart-
ment, Biomedical Sciences, University of Liverpool, Liverpool 
L69 3BX, England, UK  17a
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The control of uterine muscular activity is clearly 
necessary for successful reproduction. Our under-
standing of how these contractions arise and the role 
of intracellular Ca signals has increased greatly in the 
last decade. Despite this, preterm labors are still a com-
mon problem of childbirth, as are term labors charac-
terized by inadequate uterine contractions. We have 
sought to obtain a better understanding of how Ca 
signals spread between cells and muscle bundles in in-
tact myometrium by using confocal imaging, so that a 
more detailed explanation of how the Ca signal relates 
to force can be obtained. Our results show that the 
Ca transients in pregnant uterine tissue are composed 
of Ca spikes, which are associated with spike-like ac-
tion potentials. There is large variation in the pattern 
of spontaneous activity in myometrium, ranging from 
non-propagating Ca spikes confi   ned to individual 
smooth muscle cells, through to regional and global 
propagating Ca spikes. The Ca spikes did not show 
fi  xed initiation sites, propagated in longitudinal and 
transverse directions from the initiation regions, and 
had a variable pattern of propagation in preparations 
that were not synchronously active. In preparations 
that showed synchronous activity, Ca spikes singularly 
or bursts propagated mainly in the transverse direc-
tion from the initiation regions. The amplitude of 
force generated by single spikes was dependent on the 
number of bundles recruited by the propagating Ca 
spike within the strip, and was 30–40% of the maxi-
mal force produced by carbachol or high-K stimula-
tion. If Ca spikes appeared in the form of bursts, they 
generated longer lasting fused contractions, the am-
plitudes of which were dependent on the number and 
the frequency of Ca spikes in the burst.
We have also studied human myometrium from 
women who have Caesarean sections and characterized 
uterine activity and Ca signaling associated with diabe-
tes, dysfunctional labors, obesity, fetal distress, and post-
term pregnancies. The information from these different 
patient groups will be discussed and an attempt made to 
relate it to uterine pathophysiology.
43.  A Novel Role for Ryanodine Receptors during Em-
bryonic Development: Studies in Zebrafi  sh. HOUDINI 
HO-TIN WU, CAROLINE BRENNAN, and RACHEL 
ASHWORTH, School of Biological and Chemical Sciences, 
Queen Mary University of London, London E1 4NS, Eng-
land, UK
Embryonic development requires the coordination of 
complex intracellular signals. Calcium ions (Ca2+) play 
a variety of roles throughout early embryogenesis; how-
ever, the regulation of this messenger in this process is 
not well established. Ryanodine receptors (RyRs) are a 
family of intracellular ion channels that control calcium 
release into the cytosol. We have identifi  ed fi  ve RyR ze-
brafi  sh genes (ryr1a, 1b, 2a, 2b, and 3) in zebrafi  sh. Phy-
logenetic analysis revealed that ryr1a, ryr1b, and a single 
ryr3 gene in zebrafi  sh cluster with those from other te-
leost species. Zebrafi  sh ryr2a was found to be closely re-
lated to mammalian homologues, whereas ryr2b is more 
divergent. Semiquantitative end-point PCR and whole 
mount in situ hybridization were used to determine the 
temporal and spatial expression of RyR mRNA during 
key stages of development. Maternal expression of ryr2a, 
2b, and 3 was detected during the cleavage and blastula 
periods of zebrafi  sh development; however, the func-
tional signifi  cance of this observation remains unclear, 
as RyRs have not been implicated in very early devel-
opment. In the somites, ryr1a expression was detected 
in the slow muscle precursors before ryr1b expression 
in the fast fi  ber progenitor cells, whereas ryr3 was ex-
pressed later throughout the muscle. Expression of ryr2b 
was observed in the precardiac mesoderm from 14 hpf, 
confi  rming that this is the cardiac ryr gene in zebrafi  sh. 
The appearance of a heartbeat from 24 hpf onwards 
confi  rms the presence of a functional RyR in cardiac 
muscle, and protein expression was observed at 48 hpf. 
Finally, the ryr2a gene expression could be detected at 
several sites in the developing forebrain, midbrain, and 
hindbrain at 24 hpf. The spatial and temporal charac-
terization of ryr gene expression will facilitate research 
into the function of this family of intracellular ion chan-
nels during embryogenesis.18a
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